Mitsuboshi Belting (OTC:MBGFF) Stock, Quote.Headers.trade-ideas

Mitsuboshi Belting Ltd is involved in the business of Power transmission belts and related products, Conveyor belts and systems and related products, Engineering plastics, Engineering structural foam, Waterproofing and Watershielding sheet, Metal nanoparticle related products. Its products include automobile and motorcycle transmission belts, general industrial transmission belts, pulleys, conveyer belts, systems, engineering plastic materials and processed products, waterproofing materials for construction etc.

MITSUBOSHI BELTING LTD by Mitsuboshi Belting Ltd

Mitsuboshi Belting Ltd

B of A Securities analyst Derik De Bruin maintains Exact Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) with a Buy and lowers the price target from $75 to $72.

News

Price Target

Analyst Ratings

EXAS

B of A Securities Maintains Buy on Exact Sciences, Lowers Price Target to $72

Legal

GOOG

GOOGL

iShares MSCI Turkey Investable Market Index Fund

Google Spokesperson Says Google Intends To Appeal Turkish Competition Authority Decision; Turkish Authority Decision Does Not Take Into Account The Intense Competition Where Ad Buyers And Sellers Have Plenty Of Choice; Google Remains Committed To Supporting Turkish Businesses, Publishers And Users In This Highly Competitive Sector

<a href="https://www.tbsnews.net/tech/turkey-fines-google-75-million-violating-competition-law-1017806" title="https://www.tbsnews.net/tech/turkey-fines-google-75-million-violating-competition-law-1017806">https://www.tbsnews.net/tech/turkey-fines-google-75-million-violating-competition-law-1017806</a>

Reported Earlier, 'Turkey Fines Google $75 Million For Violating Competition Law' - Business Standard

B of A Securities analyst Derik De Bruin maintains Charles River (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) with a Neutral and lowers the price target from $220 to $210.

B of A Securities Maintains Neutral on Charles River, Lowers Price Target to $210

Apple Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) upcoming switch to in-house <a target="_blank" href="https://www.benzinga.com/topic/ai-chips" rel="noreferrer noopener">chips for</a> Bluetooth and Wi-Fi connections from 2025 will likely impact its partner&nbsp;Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>).
The Wi-Fi and Bluetooth chips will enable Apple devices to go online via wireless networks, pair with headphones, and more.
Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) manufactured Proxima, which will power Apple&#8217;s first products in 2025, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-12-12/apple-nears-switch-to-in-house-bluetooth-and-wi-fi-chip-for-iphone-home?sref=TBDibEcD" rel="noreferrer noopener">cites</a> familiar sources.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/24/12/42436800/stmicroelectronics-and-qualcomm-launch-new-iot-module-to-simplify-wireless-connectivity" rel="noreferrer noopener">STMicroelectronics and Qualcomm Launch New IoT Module to Simplify Wireless Connectivity</a>
Apple is developing an end-to-end wireless approach that is integrated with its other components. This will give it an edge in connecting devices to cellular networks and Wi-Fi hubs, paving the way for new device formats.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13063810/newplot-11.png" alt="" class="wp-image-691115" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13063810/newplot-11.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/13063810/newplot-11-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
According to the report, Apple&#8217;s component will be compatible with the Wi-Fi 6E standard.
Apple will launch the combined Wi-Fi and Bluetooth chip in 2025 under its new home devices, including refreshed TV set-top box and HomePod mini smart speaker versions.
Apple aims to introduce the components to iPhones in 2025 and iPads and Macs by 2026. However, Broadcom will still provide the radio frequency filter for modems.
Reportedly, Apple tapped Broadcom to develop a <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/24/12/42439155/broadcom-stock-jumps-on-apple-ai-chip-report-whats-going-on" rel="noreferrer noopener">server chip designed</a> for AI tasks to help meet the computing demands of its new AI features.
Prior reports indicated that the iPhone company had worked on its <a target="_blank" href="https://www.benzinga.com/general/24/05/38680360/apples-secret-project-and-bold-move-towards-in-house-ai-chips-could-this-be-a-threat-to-nvidia" rel="noreferrer noopener">Apple Chips in Data Center</a> project for several years. This project focused on developing AI inference, an area dominated by Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>). The company also tapped Taiwan Semiconductor for the chip&#8217;s design and production.
Wedbush&#8217;s Dan Ives expects Apple to reach a $4 trillion market cap by early 2025 as consumers&nbsp;resonate with the AI revolution.
Apple stock surged 34% year-to-date. Investors can gain exposure to the stock through Vanguard Information Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGT#NYSE">VGT</a>) and Fidelity MSCI Information Technology Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTEC#NYSE">FTEC</a>).
Price Action: AAPL stock is down 0.48% at $246.76 at the last check on Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42439768/innoviz-tech-stock-shoots-up-after-lidar-supply-deal-with-mobileye" target="_blank" rel="noreferrer noopener">Innoviz Technologies Secures LiDAR Supply Deal With Mobileye</a></li>
</ul>
Photo via Apple

Tech

Media

AAPL

AVGO

FTEC

NVDA

Apple's 2025 Chip Transition Targets New Wireless Edge, Broadcom To Retain Key Role

B of A Securities analyst Derik De Bruin maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Neutral and lowers the price target from $153 to $150.

B of A Securities Maintains Neutral on Agilent Technologies, Lowers Price Target to $150

During 2000–2020, the U.K.'s National Health Service (NHS) faced significant trade-offs in prioritizing new drug treatments, as resources allocated to these medications often came at the expense of broader population health gains.
Lancet research revealed that while newly approved drugs directly benefit certain patients, the overall impact on population health was negative due to the high costs and resulting resource reallocation.
A retrospective analysis reviewed technology appraisals conducted by the National Institute for Health and Care Excellence (NICE) on 332 drugs.
Of these, 276 (83%) received positive recommendations, and most were appraised within five years of regulatory approval.
The study ultimately included 183 drugs after excluding ineligible cases. While these drugs generated an estimated 3.75 million quality-adjusted life years (QALYs) across 19.82 million patients, their cost to the NHS—totaling $94.93 billion (75.1 billion pounds)—led to an estimated net loss of 1.25 million QALYs.
For example, oncology drugs demonstrated a median cost-effectiveness ratio (ICER) of 30,000 pounds per QALY gained, significantly higher than the 6,478 pounds for anti-infective drugs.
Additionally, the ICER for new drug recommendations rose by 32% from 2000 to 2020, reflecting increased financial pressures on the NHS.
Despite potential long-term benefits from price reductions after patent expiration, these effects were limited. Only 19% of the studied drugs had generic or biosimilar alternatives by 2020.
For new drugs to contribute positively to population health, their initial costs would have required a median reduction of 42%.
The ongoing debate around NICE's cost-effectiveness threshold remains central to policy discussions.
A 2024 agreement retained the current threshold until 2029, but experts argue for alignment with the Department of Health and Social Care's estimate of health-opportunity costs.
Such an adjustment could ensure the NHS achieves better value for its investments in new drugs without compromising care quality in other areas.
Balancing innovation with equitable health outcomes requires nuanced policy solutions. The study <a target="_blank" href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02352-3/fulltext" rel="noreferrer noopener">suggests</a> a lower cost-effectiveness threshold, closer to 15,000 pounds per QALY, could better align spending with health gains.
However, opposition from the pharmaceutical industry underscores the challenges of reforming pricing policies while fostering innovation.
This approach highlights how benefiting one group of patients may require deprioritizing others as existing NHS services and treatments are displaced to fund new drugs.
For instance, in 2010, NICE approved Roche Holding AG's (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>) Herceptin (trastuzumab) for metastatic gastric cancer, deeming an ICER of 43,206 pounds per QALY gained as cost-effective.
Framing this as 2.88 QALYs forgone for every QALY gained clarifies the value placed on patients receiving the treatment versus those who might lose out on care.
At a population level, using trastuzumab in this context resulted in an estimated 4,000 QALYs lost between 2010 and 2020.
However, adopting this perspective could pose challenges for policymakers due to the established 20,000–30,000 pounds per QALY threshold.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42469841/cf-industries-50m-quarterly-ebitda-potential-from-carbon-capture-credits-starting-q4-2025-analyst-says" target="_blank" rel="noreferrer noopener">CF Industries Carbon Capture Credits EBITDA Potential Could Be As High As $50 Million: Analyst</a></li>
</ul>
Photo by Martin Gregor via Shutterstock

Biotech

Government

Eurozone

Health Care

General

EWUS

FLGB

RHHBY

United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis

B of A Securities analyst Derik De Bruin maintains Waters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) with a Neutral and raises the price target from $400 to $430.

B of A Securities Maintains Neutral on Waters, Raises Price Target to $430

B of A Securities analyst Derik De Bruin maintains West Pharmaceutical Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) with a Buy and raises the price target from $350 to $355.

B of A Securities Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355

B of A Securities analyst Derik De Bruin maintains Stevanato Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) with a Buy and raises the price target from $24 to $26.

STVN

B of A Securities Maintains Buy on Stevanato Group, Raises Price Target to $26

<ul>
<li>Dividend increased by 7.3%</li>
<li>Quarterly dividend payout has increased more than 60% since 2020</li>
<li>404th consecutive quarterly dividend to be paid by Abbott since 1924</li>
</ul>
ABBOTT PARK, Ill., Dec. 13, 2024 /PRNewswire/ -- Abbott (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) today announced that its board of directors has increased the company's quarterly common dividend to 59 cents per share, an increase of 7.3%. The company's quarterly dividend&nbsp;payout has increased more than 60% since 2020.

Dividends

Abbott Increases Quarterly Dividend From $0.55 To $0.59 Per Share

Citigroup analyst Christopher Danely maintains Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Buy and raises the price target from $205 to $220.

Citigroup Maintains Buy on Broadcom, Raises Price Target to $220

On Friday, <a target="_blank" href="https://www.benzinga.com/fintech" rel="noreferrer noopener">fintech company</a> Affirm Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) stock gained after the company announced a long-term capital partnership with Sixth Street to invest up to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42483641/affirm-and-sixth-street-announce-long-term-capital-partnership-to-invest-up-to-4-billion-in-affirm" rel="noreferrer noopener">$4 billion in Affirm loans</a>. The stock gave up the gains in the trading session.
Through its Asset Based Finance platform, Sixth Street will invest up to $4 billion by purchasing Affirm loans in a unique AssetCo structure pursuant to a three-year forward flow agreement.
The transaction represents the most significant capital commitment Affirm has secured to date.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/24/12/42484240/apples-airpods-production-shifts-to-india-foxconn-will-begin-manufacturing-in-2025" rel="noreferrer noopener">Apple&#8217;s AirPods Production Shifts To India: Foxconn Will Begin Manufacturing In 2025</a>
It provides additional off-balance sheet funding, allowing Affirm to extend up to more than $20 billion in loans over the next three years as the company continues to scale its payment network.
In October, SoFi Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) announced a <a target="_blank" href="https://www.benzinga.com/news/24/10/41313080/sofi-technologies-stock-is-surging-monday-whats-going-on" rel="noreferrer noopener">$2 billion loan</a> deal with funds managed by Fortress Investment Group to develop SoFi&#8217;s capabilities in its loan platform business.
Affirm reported its <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41827055/affirm-reports-better-than-expected-q1-results-details" rel="noreferrer noopener">first-quarter&nbsp;revenue</a> of $698.47 million versus $496.54 million a year ago, which topped the analyst estimate of $664.01 million. EPS loss of 31 cents beat the consensus loss estimate of 35 cents. Affirm expects second-quarter revenue of $770 million and $810 million.
JPMorgan&#8217;s&nbsp;Reginald L. Smith&nbsp;flagged a <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42274540/fintechs-new-year-playbook-kaspi-affirm-shopify-set-the-tone-for-2025" rel="noreferrer noopener">$65 billion leap</a> in the fintech sector&#8217;s market cap since mid-September, backed by third-quarter results, rate cuts, and post-election tailwinds. Smith&nbsp;called Kaspi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>), Affirm, and&nbsp;Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) the top fintech winners.
Affirm continues to leverage the growing popularity of Buy Now, Pay Later (BNPL) services by strengthening its partnerships with Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>).
Smith emphasizes Affirm&#8217;s <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42274540/fintechs-new-year-playbook-kaspi-affirm-shopify-set-the-tone-for-2025" rel="noreferrer noopener">robust credit metrics</a> and dependable funding sources as distinguishing factors. The company aims for profitability by fiscal year 2025.
Affirm Holdings stock surged 50% year-to-date. Investors can gain exposure to the stock through Amplify Digital Payments ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPAY#NYSE">IPAY</a>) and Amplify ETF Trust Amplify Online Retail ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBUY#NYSE">IBUY</a>).
Price Action: AFRM stock is down 1.31% at $67.87 at last check on Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42435733/taiwan-semi-founder-calls-for-new-strategy-after-intel-chiefs-departure" target="_blank" rel="noreferrer noopener">Taiwan Semi Founder Calls For New Strategy After Intel Chief&#8217;s Departure</a></li>
</ul>
Photo via Company

Fintech news covering the emerging Financial Technology services sector

Fintech

AFRM

AMZN

IBUY

IPAY

KSPI

SHOP

SOFI

Affirm Secures $4 Billion Loan Deal With Sixth Street to Boost BNPL Growth

In the current session, the stock is trading at $54.75, after a 0.27% spike. Over the past month, ACI Worldwide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIW#NASDAQ">ACIW</a>) stock increased by 0.76%, and in the past year, by 84.01%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1734105640_0.png" alt="Past Year Chart" />

<h3>Comparing ACI Worldwide P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
ACI Worldwide has a lower P/E than the aggregate P/E of 114.62 of the Software industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734105640_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

ACIW

Price Over Earnings Overview: ACI Worldwide

Mama`s Creations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMA#NASDAQ">MAMA</a>) is gearing up to announce its quarterly earnings on Monday, 2024-12-16. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Mama`s Creations will report an earnings per share (EPS) of $0.04.
Anticipation surrounds Mama`s Creations's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Overview of Past Earnings</h3>
Last quarter the company beat EPS by $0.01, which was followed by a 0.44% drop in the share price the next day.
Here's a look at Mama`s Creations's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.02</td>
<td>0.02</td>
<td>0.03</td>
<td>0.04</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.03</td>
<td>0.01</td>
<td>0.04</td>
<td>0.05</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>-5.0%</td>
<td>9.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1734105633_0.png" alt="eps graph" />
<h3>Tracking Mama`s Creations's Stock Performance</h3>
Shares of Mama`s Creations were trading at $9.49 as of December 12. Over the last 52-week period, shares are up 138.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MAMA/earnings">To track all earnings releases for Mama`s Creations visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

MAMA

Mama's Creations's Earnings Outlook

The Sundance Kid hasn&#8217;t ridden off into the sunset yet, but at the rate acting legend Robert Redford is divesting his real estate portfolio, he seems intent on lightening his load. The latest of his homes listed is his cozy retreat on the Tiburon Peninsula north of San Francisco, which just hit the market for $4.15 million.
<h2 class="wp-block-heading">A Short-Lived Ownership</h2>
The wood-shingled property was built in 1968 and is nestled among tall redwoods overlooking the bay, Keil Cove, and Angel Island. Redford and his wife, artist Sibylle Szaggars Redford, haven&#8217;t owned the place for long. According to the Wall Street Journal, which broke the story, they paid $3.1 million for the four-bedroom, roughly 2,824-square-foot residence in 2020.
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a></li>
</ul>
The listing represents a flip of sorts for the couple, who embarked on some cosmetic changes to brighten things up, give it a coastal feel, and add terraces and gardens.&nbsp;
&#8220;We love Mediterranean gardens,&#8221; they said in an email to the WSJ, &#8220;and Tiburon&#8217;s climate is perfect for plants like lavender, jasmine and succulents, all water-wise plants which now grace the outdoor spaces around the home.&#8221;&nbsp;
<h2 class="wp-block-heading">A Steady Divestment Of Their Real Estate Holdings&nbsp;</h2>
The sale seems to be due because the couple cannot spend much time on the property. They live primarily in Santa Fe, N.M., where Sibylle has an art gallery. They also have homes in California and <a href="https://www.benzinga.com/content/42402790/b2i-digital-selected-as-marketing-partner-for-13th-annual-roth-deer-valley-event">Utah</a>, the latter hosting the annual Sundance Film Festival that Redford founded.
See Also: Unlock the hidden potential of commercial real estate —<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=unlockboost-yahoo"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
The couple still own homes in California and Utah and has been steadily divesting their real estate holdings in recent years. In 2019, they sold a 10-acre Napa Valley wine country home for $7 million. In 2021, the Horse Whisperer Ranch was put on the market for $4.9 million. Earlier this year, they sold a four-bedroom Utah cabin near Sundance for $3.99 million. Szaggars Redford purchased the home in the 1980s before she met the Hollywood icon.&nbsp;
<h2 class="wp-block-heading">Dedicated Conservationists</h2>
In 2020, the Redfords sold the Sundance Mountain Resort, the Provo Canyon ski destination the actor, filmmaker, and environmental activist opened in 1969. At the time of selling the 2,600-acre resort to Broadreach Capital Partners and Cedar Capital Partners, Redford told The Salt Lake Tribune:
&#8220;I had been searching for years for the right people to take it to the next level so that I could take that weight off my shoulders and enjoy my life.&#8221;
Trending: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/go/arrived-private-credit-yf">7-9% target yield with monthly dividends would you invest in it</a>?
A dedicated <a href="https://www.benzinga.com/content/42416706/historic-partnership-secures-nearly-4-000-acres-for-conservation-and-future-public-recreation-in-sou">conservationist</a>, Redford and his family have entered into a partnership with Utah Open Lands to permanently protect over 300 acres of pristine wildlife habitat, streams and wetlands. Located at the base of Mt. Timpanogos, the recently established Redford Family Elk Meadows Preserve includes the meadow below the iconic Stewart Falls and popular hiking and cross-country skiing trails.
<h2 class="wp-block-heading">A Refuge From The Spotlight</h2>
Despite the increase in the number of high-profile celebrities attracted to Utah for skiing and the film festival, Sundance has generally remained a low-key resort serving the local population from the nearby town of Provo.
Redford&#8217;s first wife was from Provo and in 1961, the actor bought two acres for $500 from the owners, a sheepherding family who ran a mom-and-pop ski operation called Timphaven. It was a refuge for Redford from Hollywood as his acting career took off.&nbsp;
Read Next:
<ul>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=jeffbezos100"> Here&#8217;s how you can earn passive income with just $100.</a></li>
</ul>

The Sundance Kid Downsizes His Real Estate Portfolio: Robert Redford's N. California Home Is The Latest Of His Residences To Hit The Market

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) has outperformed the market over the past 20 years by 5.53% on an annualized basis producing an average annual return of 13.93%. Currently, FactSet Research Systems has a market capitalization of $18.56 billion. 
Buying $1000 In FDS: If an investor had bought $1000 of FDS stock 20 years ago, it would be worth $14,122.09 today based on a price of $488.61 for FDS at the time of writing.
<h3>FactSet Research Systems's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734105611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning FactSet Research Systems Stock In The Last 20 Years

WIIM

SCHW

Charles Schwab shares are trading lower. The company reported monthly activity.

B of A Securities analyst Michael Ryskin maintains Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) with a Neutral and raises the price target from $52 to $54.

B of A Securities Maintains Neutral on Tempus AI, Raises Price Target to $54

The convergence of the beauty category with the health and wellness segment has increased the addressable market for all players, according to Goldman Sachs.
Soft demand in China and channel disruptions in the U.S. have triggered a broad selloff in the beauty category year to date, "creating attractive stock-picking opportunities," analyst Patty Kanada said in the note.
Kanada initiated coverage of two beauty stocks:
<h1 class="wp-block-heading">The elf Beauty Thesis</h1>
The analyst initiated coverage of elf Beauty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Buy rating and a price target of $165.
elf Beauty is among the "fastest growing and most disruptive players in beauty," Kanada said in the initiation note. The company has continued to gain market share and generated growth, despite softening in the beauty category, he added.
"As such, we expect the company to continue to deliver healthy topline growth fueled by a disciplined holy grail innovation strategy and disruptive marketing techniques that resonate with core Gen Z consumers," the analyst wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">The Coty Thesis</h1>
Kanada initiated coverage of Coty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Neutral rating and a price target of $9.
<a>Coty </a>has stabilized its Consumer Beauty business, while its Prestige Fragrance business remains strong, the analyst said. While the company is a "strong transformation story," the softening in the beauty category lowers the visibility into its near-term performance, he added.
"Management is optimistic trends will begin to improve in 2H25, but we take a more cautious view as we expect competition to intensify as volume scarcity grows and given softening trends for COTY in scanner data as well as HundredX consumer sentiment data," the analyst wrote. There is opportunity in the longer term, as Coty "continues to simplify its operating structure, speed up its innovation cycle and strengthen its social media marketing capabilities," he further stated.
ELF, COTY Price Actions: At the time of publication on Friday, shares of elf Beauty had risen by 2% to $134.14 and Coty's stock had declined by 1.87% to $7.33.
Read More: • <a href="https://www.benzinga.com/content/42439189/opic-technologies-inc-revolutionizes-the-beauty-industry-with-3d-live-technology">OPIC Technologies, Inc. Revolutionizes the Beauty Industry with 3D Live Technology</a>
Photo: Nomad Soul via Shutterstock

Comments

Mitsuboshi Belting

Mitsuboshi Belting (MBGFF) Forecast

Mitsuboshi Belting (OTC:MBGFF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga